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background: Ultrafiltration (UF) is an emerging treatment modality for volume overload in acute decompensated heart failure (ADHF). Recent 
randomized control trials have shown questionable benefit and evidence of adverse outcomes, including renal dysfunction. Given previous 
associations between right ventricular (RV) dysfunction and cardiorenal syndrome, we hypothesized that RV dysfunction would increase the 
risk of renal failure in patients undergoing UF. Tricuspid annular plane systolic excursion (TAPSE) is a simple, well validated measure of RV 
function. We therefore retrospectively studied patients at our institution who underwent UF to determine whether TAPSE and other transthoracic 
echocardiographic (TTE) parameters of right and left ventricular function were predictive of developing renal failure.
methods: TTE data of 14 patients admitted to our institution for ADHF who underwent UF therapy was retrospectively reviewed. TAPSE, ejection 
fraction, pulmonary artery systolic pressure, right atrial pressure, tricuspid regurgitation, and RV fractional area change were analyzed to explore 
potential interaction with increase in serum creatinine during UF therapy. Assessment of TTE values was performed according to previously published 
standards. Statistical analysis was performed using paired student t-test and analysis of variance.
results: The mean creatinine increase was 0.57 + 0.54 mg/dl in patients with reduced TAPSE and 0.05 + 0.34 mg/dl in patients with normal 
TAPSE, p = 0.049. There was no difference in mean creatinine increase based on other variables studied.
conclusions: Incidence of renal failure in patients undergoing UF for ADHF is higher in patients with RV dysfunction as measured by TAPSE. These 
patients could represent a high risk subgroup which may account for the elevated rates of renal failure demonstrated in previous study. TAPSE may 
be a simple way to prospectively identify patients at high risk of developing renal failure during UF. Further study is needed to better establish this 
potential clinical relationship to determine whether UF treatment should be avoided or modified in these patients. 
